期刊文献+

654例急性腹泻患者中致泻性病毒病原学研究 被引量:2

Etiological study on viral pathogens in 654 acute diarrhea cases
原文传递
导出
摘要 目的了解最近两年衢州地区急性腹泻患者中病毒的病原学分布特点。方法收集2011年-2012年衢州地区654例急性腹泻患者的粪便标本和流行病学资料,并进行腹泻相关病毒的多重RT-PCR和PCR检测。结果急性腹泻患者病毒检出率为19.11%(125/654),其中轮状病毒(RV)A型54例(8.26%)、C型3例(0.46%),诺如病毒(NV)GⅠ型6例(0.92%)、GⅡ型28例(4.28%),札如病毒(SAV)31例(4.74%),星状病毒(ADV)3例(0.46%);未检测到肠道腺病毒(ASV)。轮状病毒主要感染年龄为≥18岁,其他病毒在不同年龄组人群中感染率差异无统计学意义。轮状病毒发病高发期在11月至次年1月,杯状病毒的感染主要集中在2月-6月。结论衢州地区急性病毒性腹泻的病原复杂,杯状病毒是最主要病原。不同病种类病毒感染具有明显的季节性,制定防治策略时应予以重视。 Objective To investigate the etiology characteristics of virus in acute diarrhea patients in Quzhou from 2011 to 2012. Methods Epidemiologie data and fecal specimens were collected from 654 patients with acute diarrhea. Diarrhea - re- lated virus were detected by multiple RT - PCR and PCR. Results The virus detection rate was 19.11% in acute diarrhea pa- tients(125/654), including rotavirus A in 54 eases(8.26% ), rotavirus C in 3 eases(0.46% ), norovirus G I in 6 eases (0.92%), norovirus G lI in 28 casses(4.28% ), sapovirus in 31 eases(4.74% ), and astrovirus in 3 eases(0.46% ). No enteric adenovirus was found. In addition, the incidence of rotavirus was highest in people more than 18 years old. There was no significant difference in other viruses among different age groups. The peak of rotavirus diarrhea was observed from October to January of the next year, while human calieiviruses infection mainly concentrated from February to June. Conclusion Human ealicivirus was the most important pathogen of acute diarrhea among muhiple virus in Quzhou. The occurrence of different virus has obvious seasonal features, which should be given enough attention in control and prevention of acute viral diarrhea.
出处 《中国卫生检验杂志》 北大核心 2014年第4期556-558,共3页 Chinese Journal of Health Laboratory Technology
基金 衢州市科技计划项目(20111067)
关键词 病毒性腹泻 轮状病毒 杯状病毒 Viral diarrhea Rotavirus Human caliciviruses
  • 相关文献

参考文献9

二级参考文献59

共引文献261

同被引文献47

  • 1吴疆,高志勇,刘桂荣,刘园,李洁,罗明,吴晓娜,贾蕾,窦相峰,严寒秋.北京地区诺如病毒感染的流行病学调查[J].中华流行病学杂志,2007,28(7):667-670. 被引量:37
  • 2中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128.
  • 3Glass RI,Parashar UD,Estes MK.Norovirus gastroenteritis[J].N Engl J Med,2009,361(18): 1776-1785.
  • 4Mayo MA.A summary of raxonomic changes recently approved by ICTV[J].Arch Virol,2002,147(8): 1655-1656.
  • 5Hardy ME.Norovirus protein structure and function[J].FEMS Microbiol Lett,2005,253(1): 1-8.
  • 6Duizer E,Bijkerk P,Roekx B,et al.Inactivation of caliciviruses[J].Appl Environ Microbiol,2004,70(8): 4538-4543.
  • 7Dolin R.Noruviruses-challenges to control[J].N Engl J Med,2007,357 (11) : 1072-1073.
  • 8Karst SM,Zhu S,Goodfellow IG.The molecular pathology of noroviruses[J].J Pathol,2015,235(2): 206-216.
  • 9Zhou X,Li H,Sun L,et al.Epidemiological and molecular analysis of a waterborne outbreak of norovirus GII.4[J].Epidemiol Infect,2012,140(12): 2282-2289.
  • 10Larsson C,Andersson Y,Allestam G,et al.Epidemiology and estimated costs of a large waterborne outbreak of norovirus infection in Sweden[J].Epidemiol Infect,2014,142(3): 592-600.

引证文献2

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部